Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tobin

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Immunohorizons|February 20, 2020
High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell ChangesJessica S W Borgers, Richard P Tobin, Victoria M Vorwald, et al.
Journal of the National Cancer Institute|August 23, 2015
Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor CellsJongWook Hong, Nicholas P Tobin, Helene Rundqvist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II TrialJessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Journal of Neuroinflammation|June 27, 2024
Traumatic brain injury alters the effects of class II invariant peptide (CLIP) antagonism on chronic meningeal CLIP + B cells, neuropathology, and neurobehavioral impairment in 5xFAD miceJaclyn Iannucci, Reagan Dominy, Shreya Bandopadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2016
Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 SubtypesJingmei Li, Emma Ivansson, Daniel Klevebring, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II TrialJessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Cancer Research|May 20, 2016
Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated MacrophagesMajken Wallerius, Tatjana Wallmann, Margarita Bartish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2022
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical TrialAnnelie Johansson, Huma Dar, Laura J van 't Veer, et al.
Scientific Reports|April 26, 2017
Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancerKristi Krüger, Elisabeth Wik, Gøril Knutsvik, et al.
Journal of Leukocyte Biology|July 16, 2010
TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammationM K Newell, R P Tobin, J H Cabrera, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Immunohorizons|February 20, 2020
High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell ChangesJessica S W Borgers, Richard P Tobin, Victoria M Vorwald, et al.
Journal of the National Cancer Institute|August 23, 2015
Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor CellsJongWook Hong, Nicholas P Tobin, Helene Rundqvist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II TrialJessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Journal of Neuroinflammation|June 27, 2024
Traumatic brain injury alters the effects of class II invariant peptide (CLIP) antagonism on chronic meningeal CLIP + B cells, neuropathology, and neurobehavioral impairment in 5xFAD miceJaclyn Iannucci, Reagan Dominy, Shreya Bandopadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2016
Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 SubtypesJingmei Li, Emma Ivansson, Daniel Klevebring, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II TrialJessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Cancer Research|May 20, 2016
Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated MacrophagesMajken Wallerius, Tatjana Wallmann, Margarita Bartish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2022
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical TrialAnnelie Johansson, Huma Dar, Laura J van 't Veer, et al.
Scientific Reports|April 26, 2017
Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancerKristi Krüger, Elisabeth Wik, Gøril Knutsvik, et al.
Journal of Leukocyte Biology|July 16, 2010
TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammationM K Newell, R P Tobin, J H Cabrera, et al.
Pageof 15